Insider Selling: Teladoc Health, Inc. (NYSE:TDOC) Insider Sells 1,000 Shares of Stock

Teladoc Health, Inc. (NYSE:TDOC) insider Daniel Trencher sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, September 18th. The shares were sold at an average price of $21.00, for a total value of $21,000.00. Following the completion of the sale, the insider now owns 21,036 shares of the company’s stock, valued at $441,756. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Daniel Trencher also recently made the following trade(s):

• On Thursday, August 17th, Daniel Trencher sold 1,000 shares of Teladoc Health stock. The stock was sold at an average price of $22.81, for a total transaction of $22,810.00.
• On Monday, July 17th, Daniel Trencher sold 1,000 shares of Teladoc Health stock. The stock was sold at an average price of $24.66, for a total transaction of $24,660.00.

Teladoc Health Price Performance

Shares of Teladoc Health stock traded down $0.02 on Tuesday, hitting $20.75. The company had a trading volume of 4,352,521 shares, compared to its average volume of 4,454,038. Teladoc Health, Inc. has a 52 week low of $20.43 and a 52 week high of $34.73. The company has a market cap of $3.42 billion, a PE ratio of -0.83 and a beta of 1.10. The business has a 50-day simple moving average of $24.02 and a 200-day simple moving average of $24.66. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.45 and a quick ratio of 3.36.

Teladoc Health (NYSE:TDOC) last released its earnings results on Tuesday, July 25th. The health services provider reported ($0.40) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.44) by $0.04. Teladoc Health had a negative return on equity of 7.32% and a negative net margin of 158.76%. The firm had revenue of $652.41 million for the quarter, compared to analyst estimates of $649.20 million. During the same period in the previous year, the company earned ($0.44) earnings per share. Teladoc Health’s revenue was up 10.1% compared to the same quarter last year. Research analysts expect that Teladoc Health, Inc. will post -1.36 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the company. Citigroup decreased their target price on Teladoc Health from $31.00 to $29.00 in a research note on Wednesday, July 26th. StockNews.com initiated coverage on Teladoc Health in a research report on Thursday, August 17th. They set a “sell” rating for the company. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, Teladoc Health presently has an average rating of “Hold” and a consensus target price of $31.20.

Institutional Trading of Teladoc Health

A number of large investors have recently added to or reduced their stakes in the business. MetLife Investment Management LLC purchased a new stake in shares of Teladoc Health during the first quarter valued at $218,000. Panagora Asset Management Inc. boosted its holdings in shares of Teladoc Health by 18.8% in the first quarter. Panagora Asset Management Inc. now owns 16,710 shares of the health services provider’s stock worth $1,205,000 after buying an additional 2,640 shares during the period. Rhumbline Advisers increased its position in shares of Teladoc Health by 2.3% in the first quarter. Rhumbline Advisers now owns 130,916 shares of the health services provider’s stock worth $9,443,000 after acquiring an additional 2,921 shares in the last quarter. Great West Life Assurance Co. Can raised its holdings in shares of Teladoc Health by 10.8% during the first quarter. Great West Life Assurance Co. Can now owns 107,908 shares of the health services provider’s stock valued at $8,237,000 after acquiring an additional 10,559 shares during the period. Finally, Raymond James Trust N.A. raised its holdings in shares of Teladoc Health by 7.8% during the first quarter. Raymond James Trust N.A. now owns 11,451 shares of the health services provider’s stock valued at $826,000 after acquiring an additional 827 shares during the period. 77.07% of the stock is currently owned by institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company operates through two segments, Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.